20.500.12556/RUL-162189 The role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study Background. To evaluate the role of the novel quantitative imaging biomarker (QIB) SUV$_{X\%}$ of $^{18}$F-FDG uptake ex-tracted from early 18F-FDG -PET/CT scan at 4 weeks for the detection of immune-related adverse events (rAE) in a cohort of patients with metastatic melanoma (mM) patients receiving immune-checkpoint inhibitors (ICI). Patients and methods. In this prospective non-interventional, one-centre clinical study, patients with mM, receiv-ing ICI treatment, were regularly followed by $^{18}$F-FDG PET/CT. Patients were scanned at baseline, early point at week four (W4), week sixteen (W16) and week thirty-two (W32) after ICI initiation. A convolutional neural network (CNN) was used to segment three organs: lung, bowel, thyroid. QIB of irAE - SUV$_{X\%}$ - was analyzed within the target organs and correlated with the clinical irAE status. Area under the receiver-operating characteristic curve (AUROC) was used to quantify irAE detection performance. Results. A total of 242 $^{18}$F-FDG PET/CT images of 71 mM patients were prospectively collected and analysed. The early W4 scan showed improved detection only for the thyroid gland compared to W32 scan (p=0.047). The AUROC for detection of irAE in the three target organs was highest when SUV$_{X\%}$ was extracted from W16 scan and was 0.76 for lung, 0.53 for bowel and 0.81 for thyroid. SUV$_{X\%}$ extracted from W4 scan did not improve detection of irAE compared to W16 scan (lung: p = 0.54, bowel: p = 0.75, thyroid: p = 0.3, DeLong test), as well as compared to W32 scan in lungs (p = 0.32) and bowel (p = 0.3). Conclusions. Early time point $^{18}$F-FDG PET/CT at W4 did not lead to statistically significant earlier detection ofirAE. However, organ18F-FDG uptake as quantified by SUV$_{X\%}$ proved to be a consistent QIB of irAE. To better assess the role of $^{18}$F-FDG PET/CT in irAE detection, the time evolution of $^{18}$F-FDG PET/CT quantifiable inflammation would be of essence, only achievable in multi centric studies. medical imaging FDG-PET/C biomarkers immunotherapy immune checkpoint inhibitors medicinsko slikanje FDG-PET/C biomarkerji imunoterpija zaviralci imunskih kontrolnih točk true false true Angleški jezik Slovenski jezik Članek v reviji 2024-09-19 13:40:14 2024-09-19 13:40:16 2024-09-23 03:35:58 0000-00-00 00:00:00 2024 0 0 Str. 335-347 no. 3 Vol. 58 2024 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616-073 1318-2099 10.2478/raon-2024-0045 208199939 335_347_Hribernik_4413_RadiologyAndOncology.pdf 335_347_Hribernik_4413_RadiologyAndOncology.pdf 1 2B2DABBD4A42C542E68F2ECCA1AFB3C1 3b3da4df3d668c6dfc32553533bd430ccb6361a53275ea0bf1e94c021d5712c1 6ba92fb1-7681-11ef-b232-0050569b8976 https://repozitorij.uni-lj.si/Dokument.php?lang=slv&id=191375 https://www.radioloncol.com/index.php/ro/article/view/4413 0 73df5f74-7681-11ef-b232-0050569b8976 https://repozitorij.uni-lj.si/Dokument.php?lang=slv&id=191376 Fakulteta za matematiko in fiziko 0 0 0